Delisting risk
Liminatus Pharma Class A (LIMN)
Develops oncology antibodies and autologous CAR-T candidates through a license- and partner-dependent model.
$3.88
Pre-market+0.04 (+1.04%)
At close$3.84(+5.35%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions15 holders · as of Mar 31, 2026 | 2.20% | 29.5K shares | |
| Insiders1 holder · as of Apr 30, 2025 | 9.19% | 123.4K shares | |
| Strategic holders4 holders · as of Jul 14, 2026 | 32.23% | 432.9K shares | |
| Otherremainder | 56.38% | 757.4K shares |
1.34M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Institutions13F, as of Mar 31, 2026
15 holders · 1.48M shares · 6 new positions · 11 increased · 3 reduced · 3 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Citadel Advisors LLC | 677.5K | 50.44% | +606.6K | May 15, 2026 |
| 350.0K | 26.06% | +350.0Knew | May 13, 2026 | |
| Geode Capital Management, LLC | 117.8K | 8.77% | +52.7K | May 15, 2026 |
| Jane Street Group, LLC | 71.3K | 5.31% | +71.3K | May 12, 2026 |
| UBS Group AG | 54.6K | 4.06% | +35.2K | May 5, 2026 |
| Vanguard Capital Management LLC | 50.4K | 3.76% | +50.4Knew | May 15, 2026 |
| Vanguard Personalized Indexing Management, LLC | 34.7K | 2.58% | +34.7Knew | May 14, 2026 |
| Virtu Financial LLC | 27.5K | 2.04% | +27.5Knew | May 14, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Iris Acquisition Holdings LLC | 26.50% | 13D | May 8, 2025 ↗ | |
| KH Feelux Co., Ltd | 15.40% | 13G | Jun 27, 2025 ↗ | |
| Valetudo Therapeutics LLCincl. Chris Kim | 14.30% | 13D | Jul 14, 2026 ↗ | |
| Ewon Comfortech Co., Ltd. | 10.90% | 13G | Jul 6, 2026 ↗ | |
| Nongae Apple Association 1st | 5.70% | 13G | Jun 26, 2025 ↗ | |
| Red Peony Association 1st | 5.70% | 13G | Jun 26, 2025 ↗ | |
| Samda Biolab Co., Ltd. | 5.10% | 13G | Jul 22, 2026 ↗ |
Insider tradesForm 4
Latest trades
No open-market trades in the last 12 months.
CongressHouse and Senate disclosures
Not reported.
